Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.45 USD | +1.88% | +4.89% | -46.13% |
08/05 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
08/05 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.13% | 64Cr | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q1 2019 Earnings Call, Nov 06, 2018